| ACETAMINOPHEN WITH CODEINE - CAPLET (8 MG) | 02143933 | Marketed | Teva Canada Limited | Jan 2014 |
| ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE TABLETS (8 MG) | 02154234 | Marketed | Laboratoire Riva Inc. | Nov 2019 |
| APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/2 (30 MG) | 02554623 | Marketed | Apotex Inc. | May 2025 |
| APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE-CODEINE-C 1/4 (15 MG) | 02554615 | Marketed | Apotex Inc. | May 2025 |
| CALMYLIN (3.33 MG) | 00535230 | Marketed | Teva Canada Limited | Apr 2013 |
| CALMYLIN ACE (10 MG) | 02198630 | Marketed | Teva Canada Limited | Apr 2013 |
| CALMYLIN PSE WITH CODEINE (3.3 MG) | 02172917 | Marketed | Teva Canada Limited | May 2013 |
| CODEINE 30 (30 MG) | 02009757 | Marketed | Laboratoire Riva Inc. | Oct 2015 |
| CODEINE PHOSPHATE SYRUP (25 MG) | 00050024 | Marketed | Laboratoire Atlas Inc. | Dec 1986 |
| COUGH SYRUP (3.33 MG) | 00690074 | Marketed | Teva Canada Limited | Apr 2013 |
| DAMYLIN WITH CODEINE SYRUP (3.3 MG) | 02245592 | Marketed | Laboratoire Riva Inc. | Sep 2002 |
| FIORINAL-C 1/2 (30 MG) | 00176206 | Marketed | Aralez Pharmaceuticals Canada Inc. | Dec 2018 |
| FIORINAL-C 1/4 (15 MG) | 00176192 | Marketed | Aralez Pharmaceuticals Canada Inc. | Oct 2020 |
| LINCTUS CODEINE BLANC (10 MG) | 00380571 | Marketed | Laboratoire Atlas Inc. | Dec 1978 |
| MERSYNDOL WITH CODEINE (8 MG) | 02047667 | Marketed | Sanofi-Aventis Canada Inc. | Nov 2007 |
| PMS-ACETAMINOPHEN WITH CODEINE ELIXIR (8 MG) | 00816027 | Marketed | Pharmascience Inc. | Dec 1991 |
| ROBAXACET-8 (8 MG) | 01934767 | Marketed | Haleon Canada ULC | Nov 2024 |
| TEVA-CODEINE (15 MG) | 00593435 | Marketed | Teva Canada Limited | Nov 2017 |
| TEVA-CODEINE (30 MG) | 00593451 | Marketed | Teva Canada Limited | Nov 2017 |
| TEVA-COTRIDIN (10 MG) | 02169126 | Marketed | Teva Canada Limited | Mar 2018 |
| TEVA-COTRIDIN EXPECTORANT (10 MG) | 02053403 | Marketed | Teva Canada Limited | Mar 2018 |
| TEVA-EMTEC-30 (30 MG) | 00608882 | Marketed | Teva Canada Limited | Jun 2017 |
| TEVA-LENOLTEC NO. 1 (8 MG) | 00653233 | Marketed | Teva Canada Limited | Jul 2019 |
| TEVA-LENOLTEC NO. 2 (15 MG) | 00653241 | Marketed | Teva Canada Limited | Oct 2018 |
| TEVA-LENOLTEC NO. 3 (30 MG) | 00653276 | Marketed | Teva Canada Limited | Oct 2018 |
| TEVA-LENOLTEC NO. 4 (60 MG) | 00621463 | Marketed | Teva Canada Limited | Oct 2018 |
| TEVA-TECNAL C 1/2 (30 MG) | 00608181 | Marketed | Teva Canada Limited | Nov 2017 |
| TEVA-TECNAL C 1/4 (15 MG) | 00608203 | Marketed | Teva Canada Limited | Nov 2017 |
| TRIATEC-30 (30 MG) | 00789828 | Marketed | Laboratoire Riva Inc. | Oct 2015 |
| ACETAMINOPHEN 300MG, CAFFEINE & CODEINE (8 MG) | 02277816 | Approved | Tanta Pharmaceuticals Inc | Feb 2006 |
| ACETAMINOPHEN 325 MG CAFFEINE AND CODEINE (8 MG) | 02271834 | Approved | Tanta Pharmaceuticals Inc | Sep 2005 |
| ACETAMINOPHEN 500MG, CAFFEINE AND 8MG CODEINE PHOSPHATE (8 MG) | 02259001 | Approved | CellChem Pharmaceuticals Inc. | Jan 2020 |
| ACETAMINOPHEN ELIXIR WITH 8MG CODEINE PHOSPHATE SYRUP (8 MG) | 02298708 | Approved | JAMP Pharma Corporation | Aug 2007 |
| ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE TABLETS (8 MG) | 02246085 | Dormant | JAMP Pharma Corporation | Aug 2017 |
| ACETAMINOPHEN, CAFFEINE AND 8 MG OF CODEINE PHOSPHATE TABLETS (8 MG) | 02248817 | Dormant | CellChem Pharmaceuticals Inc. | May 2019 |
| ACETAMINOPHEN, CAFFEINE, AND 8MG OF CODEINE PHOSPHATE TABLETS (8 MG) | 02251914 | Dormant | CellChem Pharmaceuticals Inc. | Jul 2020 |
| ACETYLSALICYLIC ACID, CAFFEINE AND 8 MG CODEINE PHOSPHATE (8 MG) | 00095494 | Dormant | CellChem Pharmaceuticals Inc. | Feb 2020 |
| APO-ACETACO #1 (8 MG) | 02265052 | Approved | Apotex Inc. | Feb 2005 |
| CODEINE 15 (15 MG) | 02009889 | Dormant | Laboratoire Riva Inc. | Nov 2021 |
| COUGH AND ALLERGY SYRUP WITH CODEINE (3.3 MG) | 02486903 | Dormant | Laboratoire Riva Inc. | Jul 2025 |
| COUGH SYRUP WITH CODEINE (3.3 MG) | 02258099 | Dormant | JAMP Pharma Corporation | Aug 2017 |
| COUGH SYRUP WITH CODEINE (3.3 MG) | 02322196 | Approved | CellChem Pharmaceuticals Inc. | Jan 2020 |
| DAMYLIN AVEC CODEINE SIROP (3.3 MG) | 02245019 | Approved | Laboratoire Atlas Inc. | Nov 2001 |
| MUSCLE AND BACK PAIN RELIEF - 8 TABLETS (8 MG) | 02250551 | Dormant | CellChem Pharmaceuticals Inc. | Feb 2020 |
| MUSCLE AND BACK PAIN RELIEF CAPLETS (8 MG) | 02258978 | Approved | JAMP Pharma Corporation | Sep 2004 |
| TRIANAL C¼ (15 MG) | 02242406 | Dormant | Laboratoire Riva Inc. | Jul 2020 |
| TRIANAL C½ (30 MG) | 01971387 | Dormant | Laboratoire Riva Inc. | Aug 2020 |
| TRIATEC-8 (8 MG) | 00852163 | Dormant | Laboratoire Riva Inc. | Jun 2019 |
| TRIATEC-8 FORT (8 MG) | 01977881 | Dormant | Laboratoire Riva Inc. | Jul 2017 |
| WAMPOLE-ACETAMINOPHEN/CODEINE/CAFFEINE (8 MG) | 02453703 | Dormant | JAMP Pharma Corporation | Aug 2019 |
| (EXTRA STRENGTH) ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE CAPLETS (8 MG) | 02236871 | Cancelled Post Market | Stanley Pharmaceuticals, A Division Of Vita Health Products Inc. | Jul 2002 |
| 222 TABLETS (8 MG) | 00108162 | Cancelled Post Market | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Aug 2015 |
| 282 MEP TAB (15 MG) | 00108316 | Cancelled Post Market | Merck Frosst Canada & Cie, Merck Frosst Canada & Co. | Aug 1998 |
| 282 TAB (15 MG) | 00108103 | Cancelled Post Market | Merck Frosst Canada & Cie, Merck Frosst Canada & Co. | Apr 1998 |
| 282 TABLETS (15 MG) | 02234510 | Cancelled Post Market | Pendopharm Division Of Pharmascience Inc | May 2021 |
| 292 TAB (30 MG) | 00219843 | Cancelled Post Market | Merck Frosst Canada & Cie, Merck Frosst Canada & Co. | Aug 1998 |
| 292 TABLETS (30 MG) | 02238645 | Cancelled Post Market | Pendopharm Division Of Pharmascience Inc | Apr 2021 |
| A & C TABLETS WITH CODEINE 15MG (15 MG) | 00095508 | Cancelled Post Market | D.C. Labs Limited | Jul 2003 |
| A & C TABLETS WITH CODEINE 30MG (30 MG) | 00095516 | Cancelled Post Market | D.C. Labs Limited | Jul 2003 |
| A.C. & C 8MG TAB (8 MG) | 00180041 | Cancelled Post Market | Vita Health Products Inc. | Sep 2019 |
| A.C. & C. 8 MG (8 MG) | 02245670 | Cancelled Pre Market | Laboratoires Confab Inc. | Apr 2021 |
| A.C. & C. 8MG (8 MG) | 02230426 | Cancelled Pre Market | Westcan Pharmaceuticals Ltd. | Aug 2017 |
| A.C.& C TABLETS (8 MG) | 01922246 | Cancelled Post Market | Pharmascience Inc. | Jun 2019 |
| AC AND C TAB 1/8GR (8 MG) | 00589470 | Cancelled Post Market | Pharmascience Inc. | Sep 2013 |
| AC&C TABLETS (8 MG) | 00688851 | Cancelled Post Market | Vita Health Products Inc. | Jul 2005 |
| AC&C TABLETS (8 MG) | 02303299 | Cancelled Post Market | Pharmascience Inc. | Jun 2019 |
| ACET 2 (15 MG) | 00706515 | Cancelled Post Market | Pharmascience Inc. | May 2013 |
| ACET 3 (30 MG) | 00706523 | Cancelled Post Market | Pharmascience Inc. | May 2013 |
| ACET CODEINE 30 (30 MG) | 01999648 | Cancelled Post Market | Pharmascience Inc. | Nov 2018 |
| ACET CODEINE 60 (60 MG) | 01999656 | Cancelled Post Market | Pharmascience Inc. | Dec 2018 |
| ACETAMINOPHEN 325 C & C (8 MG) | 02229962 | Cancelled (Unreturned Annual) | Technilab Pharma Inc. | Sep 2017 |
| ACETAMINOPHEN 325 MG WITH 15 MG CAFFEINE AND 8 MG CODEINE PHOSPHATE (8 MG) | 00706221 | Cancelled Post Market | Vita Health Products Inc. | Sep 2017 |
| ACETAMINOPHEN 500 MG COMPOUND TABLETS WITH CODEINE (8 MG) | 00617059 | Cancelled Post Market | Pharmascience Inc. | Oct 2016 |
| ACETAMINOPHEN 500 MG WITH 15 MG CAFFEINE AND 8 MG CODEINE PHOSPHATE (8 MG) | 00708712 | Cancelled Post Market | Vita Health Products Inc. | Jul 2014 |
| ACETAMINOPHEN CAFFEINE & 8MG COD. PHOS. TAB (8 MG) | 01997688 | Cancelled Post Market | Novopharm Limited | Dec 2012 |
| ACETAMINOPHEN COMPOUND TABLETS WITH CODEINE 8MG (8 MG) | 00599131 | Cancelled Post Market | D.C. Labs Limited | Jul 2005 |
| ACETAMINOPHEN W CODEINE TAB (8 MG) | 00589489 | Cancelled Post Market | Pharmascience Inc. | Sep 2013 |
| ACETAMINOPHEN, CAFFEINE & 8MG CODEINE PHOSPHATE (8 MG) | 02237420 | Cancelled Post Market | Pharmascience Inc. | Sep 2017 |
| ACETAMINOPHEN, CAFFEINE & CODEINE (8 MG) | 02028174 | Cancelled Post Market | Pharmascience Inc. | Jun 2019 |
| ACETAMINOPHEN, CAFFEINE & CODEINE (8 MG) | 02025337 | Cancelled Post Market | Pharmascience Inc. | Jun 2019 |
| ACETAMINOPHEN, CAFFEINE & CODEINE TABLETS (8 MG) | 02387255 | Cancelled Pre Market | Pharmascience Inc. | Jun 2019 |
| ACETAMINOPHEN-CAFFEINE-CODEINE (8 MG) | 02254700 | Cancelled Pre Market | Laboratoires Confab Inc. | Apr 2021 |
| ACETAMINOPHENE CODEINE ET CAFEINE CAPLETS (8 MG) | 01996541 | Cancelled Post Market | Laboratoire Riva Inc. | Jun 2019 |
| ACETAMINOPHENE CODEINE ET CAFEINE FORT (8 MG) | 01996568 | Cancelled Post Market | Laboratoire Riva Inc. | Jun 2019 |
| ACETAZONE FORTE C8 (8 MG) | 00834319 | Cancelled Post Market | Teva Canada Limited | Nov 2021 |
| ACETYLSALICYLIC ACID, CAFFEINE & 8 MG CODEINE PHOSPHATE TABLETS (8 MG) | 02246103 | Cancelled Post Market | JAMP Pharma Corporation | Sep 2022 |
| AMBENYL COUGH SYRUP (10 MG) | 00469122 | Cancelled Post Market | Parke-Davis Division, Warner-Lambert Canada Inc. | Aug 1997 |
| ANACIN WITH CODEINE TAB (8 MG) | 01933515 | Cancelled Post Market | Whitehall-Robins Inc. | Jul 2000 |
| ASA, CAFFEINE & 8MG CODEINE PHOSPHATE (8 MG) | 02238961 | Cancelled Post Market | Canapharm Manufacturing Inc | Aug 2006 |
| ASA-CAFFEINE-CODEINE (8 MG) | 02250683 | Cancelled Pre Market | Laboratoires Confab Inc. | Apr 2021 |
| ATASOL 15 (15 MG) | 00293504 | Cancelled Post Market | Church & Dwight Canada Corp. | Feb 2020 |
| ATASOL 30 (30 MG) | 00293512 | Cancelled Post Market | Church & Dwight Canada Corp. | Apr 2019 |
| ATASOL 8 (8 MG) | 00293490 | Cancelled Post Market | Church & Dwight Canada Corp. | Dec 2017 |
| AXACET-C1/8 (8 MG) | 02237996 | Cancelled (Unreturned Annual) | Technilab Pharma Inc. | Sep 2017 |
| AXISAL-C1/8 (8 MG) | 02237997 | Cancelled (Unreturned Annual) | Technilab Pharma Inc. | Sep 2017 |
| BALMINIL CODEINE + DECONGESTANT + EXPECTORANT (3.3 MG) | 02244011 | Cancelled Post Market | Rougier Pharma Division Of Ratiopharm Inc | Oct 2015 |
| BALMINIL CODEINE NIGHT TIME + EXPECTORANT (3.33 MG) | 02244010 | Cancelled Post Market | Rougier Pharma Division Of Ratiopharm Inc | Oct 2015 |
| BENYLIN 2 COLD AND FLU WITH CODEINE (3.3 MG) | 02245709 | Cancelled Post Market | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Aug 2015 |
| BENYLIN CODEINE 3.3MG DE SYR (3.3 MG) | 01944703 | Cancelled Post Market | Pfizer Canada Inc., Consumer Healthcare Division | Jul 2003 |
| BRONCODEINE SYR (10 MG) | 00779539 | Cancelled Post Market | Rougier Pharma Division Of Ratiopharm Inc | Sep 1999 |
| C T ACETYLSALICYLIC ACID CODEINE AND CAF TAB (8 MG) | 01908596 | Cancelled Post Market | Pharmavite Laboratories (1987) Inc. | Jul 2006 |
| C-2 BUFFERED WITH CODEINE (8 MG) | 02238670 | Cancelled Post Market | Pharmascience Inc. | Oct 2016 |
| C2 BUFFERED WITH CODEINE TAB (8 MG) | 00693979 | Cancelled Post Market | Wampole Brands, A Division Of Pangeo Pharma (Canada) Inc. | Jun 1999 |
| C2 TAB WITH CODEINE (8 MG) | 00693952 | Cancelled Post Market | Wampole Brands, A Division Of Pangeo Pharma (Canada) Inc. | Sep 1996 |
| CALMYLIN CODEINE D-E SYR (3.3 MG) | 00889873 | Cancelled Post Market | Technilab Pharma Inc. | Aug 1997 |
| CHERACOL COUGH SYRUP (10 MG) | 01951564 | Cancelled Post Market | Shire Pharma Canada Ulc | Jul 2003 |
| COACTIFED (20 MG) | 00068608 | Cancelled Post Market | Glaxosmithkline Inc | Mar 2015 |
| COACTIFED (10 MG) | 00068756 | Cancelled Post Market | Glaxosmithkline Inc | Nov 2014 |
| COACTIFED (10 MG) | 00068594 | Cancelled Post Market | Glaxosmithkline Inc | May 2018 |
| CODEINE PHOSPHATE INJ 30MG/ML (30 MG) | 00497282 | Cancelled Post Market | Hospira Healthcare Corporation | Sep 2018 |
| CODEINE PHOSPHATE INJ 60MG/ML (60 MG) | 00497290 | Cancelled Post Market | Hospira Healthcare Corporation | Sep 2018 |
| CODEINE PHOSPHATE INJECTION USP (30 MG) | 00544884 | Cancelled Post Market | Sandoz Canada Inc. | Jul 2024 |
| CODEINE PHOSPHATE SYRUP (5 MG) | 00093114 | Cancelled Post Market | D.C. Labs Limited | Jul 2005 |
| CODEINE PHOSPHATE TAB 15MG (15 MG) | 00093122 | Cancelled Post Market | D.C. Labs Limited | Jul 2003 |
| CODEINE PHOSPHATE TAB 30MG (30 MG) | 00093130 | Cancelled Post Market | D.C. Labs Limited | Jul 2003 |
| CODEINE PHOSPHATE TAB 60MG (60 MG) | 00093149 | Cancelled Post Market | D.C. Labs Limited | Jul 2003 |
| CODEINE TAB 15MG (15 MG) | 00779458 | Cancelled Post Market | Rougier Pharma Division Of Ratiopharm Inc | Oct 2015 |
| CODEINE TAB 30MG (30 MG) | 00779466 | Cancelled Post Market | Rougier Pharma Division Of Ratiopharm Inc | Sep 1999 |
| CORYPHEN 325 CODEINE 30 TAB (30 MG) | 00406112 | Cancelled Post Market | Rougier Pharma Division Of Ratiopharm Inc | Sep 1999 |
| CORYPHEN 650 CODEINE 30 TAB (30 MG) | 00406104 | Cancelled Post Market | Rougier Pharma Division Of Ratiopharm Inc | Sep 1999 |
| COTABS (8 MG) | 00162965 | Cancelled Post Market | Pharmavite Laboratories (1987) Inc. | Aug 2000 |
| COTRIFED (10 MG) | 00809144 | Cancelled Post Market | Technilab Pharma Inc. | Aug 1997 |
| COUGH SYR W CODEINE DIPHENHYD HCL & AMMON CL (3.3 MG) | 00792160 | Cancelled Post Market | Stanley Pharmaceuticals, A Division Of Vita Health Products Inc. | Aug 1997 |
| COUGH SYR W.COD. PSEUDOEPHED.HCL GUAIFENESIN (3.3 MG) | 02024810 | Cancelled Post Market | Stanley Pharmaceuticals, A Division Of Vita Health Products Inc. | Jul 2002 |
| COUGH SYRUP WITH CODEINE (3.3 MG) | 02099748 | Cancelled Post Market | Teva Canada Limited | Jul 2026 |
| COVAN SYRUP (10 MG) | 02243063 | Cancelled Post Market | Pharmascience Inc. | Jul 2025 |
| DIMETANE EXPECTORANT C (2 MG) | 02244079 | Cancelled Post Market | Foundation Consumer Brands, Llc | Dec 2021 |
| DIMETANE EXPECTORANT-C SYR (10 MG) | 01934716 | Cancelled Post Market | Whitehall-Robins Inc. | Apr 2001 |
| DIMETAPP-C (2 MG) | 02244078 | Cancelled Post Market | Foundation Consumer Brands, Llc | Dec 2021 |
| DIMETAPP-C SYR (10 MG) | 01934694 | Cancelled Post Market | Whitehall-Robins Inc. | Apr 2001 |
| EMPRACET-30 (30 MG) | 00666130 | Cancelled Post Market | Glaxosmithkline Inc | May 2002 |
| EMPRACET-60 (60 MG) | 00666149 | Cancelled Post Market | Glaxosmithkline Inc | May 2002 |
| EXDOL 15TAB (15 MG) | 00372331 | Cancelled Post Market | Merck Frosst Canada & Cie, Merck Frosst Canada & Co. | Apr 1998 |
| EXDOL 30TAB (30 MG) | 00372358 | Cancelled Post Market | Merck Frosst Canada & Cie, Merck Frosst Canada & Co. | Apr 1998 |
| EXDOL 8 TAB (8 MG) | 00372323 | Cancelled Post Market | Merck Frosst Canada & Cie, Merck Frosst Canada & Co. | Apr 1998 |
| EXDOL-15 (15 MG) | 02232388 | Cancelled Post Market | Pharmascience Inc. | Jul 2016 |
| EXDOL-30 (30 MG) | 02232389 | Cancelled Post Market | Pharmascience Inc. | Jul 2016 |
| EXDOL-8 (8 MG) | 02232387 | Cancelled Post Market | Pharmascience Inc. | Jul 2016 |
| METHOXACET-C 1/8 (8 MG) | 02236872 | Cancelled Post Market | Teva Canada Limited | Nov 2018 |
| METHOXISAL-C 1/2 (32.4 MG) | 01966375 | Cancelled Post Market | Teva Canada Limited | Nov 2018 |
| METHOXISAL-C 1/4 (16.2 MG) | 01966367 | Cancelled Post Market | Teva Canada Limited | Nov 2018 |
| METHOXISAL-C 1/8 (8 MG) | 01941895 | Cancelled Post Market | Teva Canada Limited | Mar 2019 |
| MUSCLE & BACK PAIN RELIEF - 8 (8 MG) | 02242180 | Cancelled Post Market | Vita Health Products Inc. | Sep 2019 |
| MUSCLE & BACK PAIN RELIEF-8 (8 MG) | 02243047 | Cancelled Post Market | Pharmascience Inc. | Oct 2016 |
| MUSCLE AND BACK PAIN RELIEF-8 (8 MG) | 02248977 | Cancelled Post Market | Teva Canada Limited | Aug 2021 |
| NEO PECTOL (65 MG) | 00147656 | Cancelled Post Market | Neolab Inc | Aug 2008 |
| NOVAHISTEX C (15 MG) | 02049465 | Cancelled Post Market | Aventis Pharma Inc. | Jul 2001 |
| NOVO AC AND C 8MG TAB (8 MG) | 00426865 | Cancelled Post Market | Novopharm Limited | Oct 2015 |
| NOVO-GESIC C15 (15 MG) | 00687200 | Cancelled Post Market | Novopharm Limited | Feb 2003 |
| NOVO-GESIC C30 (30 MG) | 00687219 | Cancelled Post Market | Novopharm Limited | Feb 2003 |
| NOVO-GESIC-C8 (8 MG) | 00615528 | Cancelled Post Market | Novopharm Limited | Oct 2015 |
| NU-ACETACO #1 (8 MG) | 02336472 | Cancelled (Unreturned Annual) | Nu-Pharm Inc | Mar 2018 |
| ORADRINE TABLETS (8 MG) | 00763527 | Cancelled Post Market | Pharmavite Laboratories (1987) Inc. | Mar 2001 |
| PAINEX TAB 0.25GR (15 MG) | 00294942 | Cancelled Post Market | Icn Canada Ltd. | Aug 1998 |
| PAINEX TAB 0.5GR (30 MG) | 00295124 | Cancelled Post Market | Icn Canada Ltd. | Aug 1998 |
| PARAFON FORTE C8 W CODEINE TAB (8 MG) | 00614920 | Cancelled Post Market | Mcneil Pharmaceutical, Division Of Ortho-Mcneil Inc. | Nov 1999 |
| PAVERAL LIQ 10MG/ML (10 MG) | 00779482 | Cancelled Post Market | Rougier Pharma Division Of Ratiopharm Inc | Sep 1999 |
| PHENAPHEN NO 2 CAP (16.2 MG) | 01909290 | Cancelled Post Market | Ayerst Laboratories | Aug 1999 |
| PHENAPHEN NO 3 CAP (32.4 MG) | 01909312 | Cancelled Post Market | Ayerst Laboratories | Sep 1996 |
| PHENAPHEN NO 4 CAP (64.8 MG) | 01909304 | Cancelled Post Market | Ayerst Laboratories | Aug 1999 |
| PHENAPHEN NO.2 CAP (16.2 MG) | 02042851 | Cancelled Post Market | Wyeth-Ayerst Canada Inc. | Aug 2001 |
| PHENAPHEN NO.3 CAP (32.4 MG) | 02042878 | Cancelled Post Market | Wyeth-Ayerst Canada Inc. | Jul 2004 |
| PHENAPHEN NO.4 CAP (64.8 MG) | 02042886 | Cancelled Post Market | Wyeth-Ayerst Canada Inc. | May 2002 |
| PHENERGAN EXPECTORANT WITH CODEINE LIQ (10 MG) | 01937545 | Cancelled Post Market | Rhone-Poulenc Rorer Consumer Inc. | Aug 1997 |
| PHENERGAN EXPECTORANT WITH CODEINE LIQUID (10 MG) | 02162180 | Cancelled Post Market | Columbia Laboratories Canada Inc. | Jul 2006 |
| PHENERGAN VC EXPECTORANT W CODEINE LIQ (10 MG) | 01937561 | Cancelled Post Market | Rhone-Poulenc Rorer Consumer Inc. | Aug 1997 |
| PHL-ACET-CODEINE 30 (30 MG) | 02254271 | Cancelled Post Market | Pharmel Inc. | Jul 2004 |
| PHL-ACET-CODEINE 60 (60 MG) | 02254263 | Cancelled Post Market | Pharmel Inc. | Jul 2004 |
| PMS-CODEINE (15 MG) | 02243978 | Cancelled Post Market | Pharmascience Inc. | Apr 2019 |
| PMS-CODEINE (30 MG) | 02243979 | Cancelled Post Market | Pharmascience Inc. | Apr 2019 |
| PMS-PHARNAL-C 1/4 CAPSULES (15 MG) | 02232985 | Cancelled Pre Market | Pharmascience Inc. | Aug 2017 |
| PMS-PHARNAL-C1/2 CAPSULES (30 MG) | 02232986 | Cancelled Pre Market | Pharmascience Inc. | Aug 2017 |
| PRACET 30 (30 MG) | 02290359 | Cancelled Pre Market | Laboratoire Riva Inc. | Jan 2016 |
| PROCET-30 (30 MG) | 02232658 | Cancelled Post Market | Pro Doc Limitee | Nov 2019 |
| PRONAL - C1/2 CAPSULES (30 MG) | 02229734 | Cancelled Post Market | Pro Doc Limitee | Jan 2013 |
| PRONAL C1/4 CAPSULES (15 MG) | 02229735 | Cancelled Post Market | Pro Doc Limitee | Jan 2013 |
| RATIO-CODEINE (5 MG) | 00779474 | Cancelled Post Market | Teva Canada Limited | May 2017 |
| ROBAXISAL C 1/2 (32.4 MG) | 01934791 | Cancelled Post Market | Glaxosmithkline Consumer Healthcare Ulc | Dec 2025 |
| ROBAXISAL C 1/4 (16.2 MG) | 01934783 | Cancelled Post Market | Glaxosmithkline Consumer Healthcare Ulc | Dec 2025 |
| ROBAXISAL C-1/8 TABLETS (8 MG) | 01934775 | Cancelled Post Market | Wyeth Consumer Healthcare Inc. | Aug 2012 |
| ROBITUSSIN AC (10 MG) | 01934740 | Cancelled Post Market | Glaxosmithkline Consumer Healthcare Ulc | Sep 2023 |
| ROBITUSSIN SYRUP WITH CODEINE (3.3 MG) | 01934732 | Cancelled Post Market | Wyeth Consumer Healthcare Inc. | Aug 2004 |
| ROUNOX AVEC CODEINE 15TAB (15 MG) | 00440809 | Cancelled Post Market | Rougier Pharma Division Of Ratiopharm Inc | Sep 1999 |
| ROUNOX CODEINE 30 TAB (30 MG) | 00477664 | Cancelled Post Market | Rougier Pharma Division Of Ratiopharm Inc | Sep 1999 |
| ROUNOX CODEINE 60 TAB (60 MG) | 00477672 | Cancelled Post Market | Rougier Pharma Division Of Ratiopharm Inc | Sep 1999 |
| ROUTEC AND CODEINE 30 - TAB (30 MG) | 02209748 | Cancelled Post Market | Rougier Pharma Division Of Ratiopharm Inc | Sep 1999 |
| SINUTAB WITH CODEINE TABLETS (8 MG) | 01938363 | Cancelled Post Market | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Aug 2015 |
| SIROP COCILLANA CODEINE (.667 MG) | 00593168 | Cancelled Post Market | Laboratoire Atlas Inc. | Jan 2017 |
| SPASMHALT-8 (8 MG) | 02237578 | Cancelled Post Market | Pendopharm Division Of Pharmascience Inc | Jul 2022 |
| SPASMHALT-ASA-8 (8 MG) | 02237580 | Cancelled Post Market | Pendopharm Division Of Pharmascience Inc | Aug 2013 |
| STANLEY SYRUP W CODEINE PHOSPHATE (5 MG) | 00470651 | Cancelled Post Market | Stanley Pharmaceuticals, A Division Of Vita Health Products Inc. | Aug 1997 |
| SUPPRESS COUGH SYR W.COD.DIPHEN.HCL AMM.CHL. (3.3 MG) | 02190575 | Cancelled Post Market | Stanley Pharmaceuticals, A Division Of Vita Health Products Inc. | Jul 2002 |
| TUSSAMINIC C FORTE SYRUP (15 MG) | 01925954 | Cancelled Post Market | Novartis Consumer Health Canada Inc. | Apr 2001 |
| TUSSAMINIC C PEDIATRIC SYRUP (5 MG) | 01906682 | Cancelled Post Market | Novartis Consumer Health Canada Inc. | Jul 2000 |
| TYLENOL NO 1 TAB (8 MG) | 00425362 | Cancelled Post Market | Mcneil Pharmaceutical, Division Of Ortho-Mcneil Inc. | Sep 1996 |
| TYLENOL NO.1 CAPLETS (8 MG) | 02181061 | Cancelled Post Market | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Sep 2016 |
| TYLENOL NO.1 FORTE CAPLETS (8 MG) | 02181088 | Cancelled Post Market | McNeil Consumer Healthcare, division of Johnson & Johnson Inc. | Aug 2015 |
| TYLENOL NO1 FORTE TABLETS WITH CODEINE (8 MG) | 00630594 | Cancelled Post Market | Mcneil Pharmaceutical, Division Of Ortho-Mcneil Inc. | Sep 1996 |
| TYLENOL W CODEINE NO2 TAB (15 MG) | 00425370 | Cancelled Post Market | Mcneil Pharmaceutical, Division Of Ortho-Mcneil Inc. | Sep 1996 |
| TYLENOL W CODEINE NO3 TAB (30 MG) | 00425389 | Cancelled Post Market | Mcneil Pharmaceutical, Division Of Ortho-Mcneil Inc. | Sep 1996 |
| TYLENOL W CODEINE NO4 TAB (60 MG) | 00396516 | Cancelled Post Market | Mcneil Pharmaceutical, Division Of Ortho-Mcneil Inc. | Sep 1996 |
| TYLENOL WITH CODEINE ELIXIR (8 MG) | 00685143 | Cancelled Post Market | Mcneil Pharmaceutical, Division Of Ortho-Mcneil Inc. | Sep 1996 |
| TYLENOL WITH CODEINE ELIXIR (8 MG) | 02163942 | Cancelled Post Market | Janssen Inc. | Jul 2013 |
| TYLENOL WITH CODEINE NO. 2 - TAB (15 MG) | 02163934 | Cancelled Post Market | Janssen Inc. | Sep 2020 |
| TYLENOL WITH CODEINE NO. 3 - TAB (30 MG) | 02163926 | Cancelled Post Market | Janssen Inc. | Sep 2020 |
| TYLENOL WITH CODEINE NO. 4 (60 MG) | 02163918 | Cancelled Post Market | Janssen Inc. | Sep 2020 |